These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

886 related items for PubMed ID: 19372173

  • 1. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J.
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why monotherapy?
    Williams KJ.
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i18-20. PubMed ID: 19372175
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I, Sanz MA.
    Enferm Infecc Microbiol Clin; 1999 May; 17 Suppl 2():95-102. PubMed ID: 10605194
    [Abstract] [Full Text] [Related]

  • 8. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

  • 9. Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study.
    Slobbe L, Waal Lv, Jongman LR, Lugtenburg PJ, Rijnders BJ.
    Eur J Cancer; 2009 Nov; 45(16):2810-7. PubMed ID: 19647995
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Moulds: diagnosis and treatment.
    Verweij PE, Maertens J.
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i31-5. PubMed ID: 19372180
    [Abstract] [Full Text] [Related]

  • 12. Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use.
    Sugar AM.
    Arch Intern Med; 1990 Nov; 150(11):2258-64. PubMed ID: 2241435
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial prophylaxis for infection in neutropenic patients.
    Bodey GP.
    Curr Clin Top Infect Dis; 1988 Nov; 9():1-43. PubMed ID: 3077285
    [No Abstract] [Full Text] [Related]

  • 14. Empirical antifungal therapy in selected patients with persistent febrile neutropenia.
    Aguilar-Guisado M, Espigado I, Cordero E, Noguer M, Parody R, Pachón J, Cisneros JM.
    Bone Marrow Transplant; 2010 Jan; 45(1):159-64. PubMed ID: 19525983
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, Kuderer NM, Langston AA, Marr KA, Rolston KV, Ramsey SD.
    J Clin Oncol; 2013 Feb 20; 31(6):794-810. PubMed ID: 23319691
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin.
    Martino R, Viscoli C.
    Br J Haematol; 2006 Jan 20; 132(2):138-54. PubMed ID: 16398648
    [Abstract] [Full Text] [Related]

  • 19. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis.
    Blijlevens NM, Logan RM, Netea MG.
    J Antimicrob Chemother; 2009 May 20; 63 Suppl 1():i36-40. PubMed ID: 19372181
    [Abstract] [Full Text] [Related]

  • 20. Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.
    Shenep JL.
    NCI Monogr; 1990 May 20; (9):117-22. PubMed ID: 2342588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.